The spectrum of haemostatic characteristics of women with unexplained menorrhagia
- 6 October 2010
- journal article
- Published by Wiley in Haemophilia
- Vol. 17 (1), e223-e229
- https://doi.org/10.1111/j.1365-2516.2010.02382.x
Abstract
While an estimated 13% of women with unexplained menorrhagia have von Willebrand disease (VWD), the frequency of other potential bleeding disorders has been uncertain. This study describes the relatively wide range of laboratory characteristics of women with unexplained menorrhagia and presents issues affecting diagnosis in this population. Women with pictorial blood assessment chart (PBAC) score > 100 were identified at six U.S. sites and asked to remain drug free for 10 days prior to testing. Blood was collected on one of the first four menstrual cycle days and tested at a central laboratory for procoagulant factors, VWD and fibrinolytic factors. Platelet function testing by PFA-100® (PFA) and platelet aggregation with ATP release (PAGG/ATPR) were performed locally using standardized methods. Among 232 subjects, a laboratory abnormality was found in 170 (73.3%), including 124 of 182 White (68.1%) and 34 of 37 Black (91.9%) subjects; 6.0% had VWD, 56.0% had abnormal PAGG/ATPR, 4.7% had a non-VWD coagulation defect (NVCD) and 6.5% had an abnormal PFA only. AGG/ATPR was reduced in 58.9% of subjects, with multiple agonists in 28.6%, a single agonist in 6.1% and ristocetin alone in 24.2%. Frequencies of PAGG/ATPR defects varied by study site and race; frequencies of VWD and NVCD were similar. Laboratory abnormalities of haemostasis, especially platelet function defects, were common among women with unexplained menorrhagia across multiple U.S. sites. To what degree these abnormalities are clinically significant requires further study.Keywords
This publication has 21 references indexed in Scilit:
- Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor functionJournal of Thrombosis and Haemostasis, 2009
- Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acidBritish Journal of Haematology, 2009
- Platelet glycoprotein VI‐related clinical defectsBritish Journal of Haematology, 2007
- Variability in clinical laboratory practice in testing for disorders of platelet functionThrombosis and Haemostasis, 2005
- von Willebrand disease in women with menorrhagia: a systematic reviewBJOG: An International Journal of Obstetrics and Gynaecology, 2004
- Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African‐American womenAmerican Journal of Hematology, 2001
- von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagiaObstetrics & Gynecology, 2001
- Bleeding problems in factor XI deficient womenHaemophilia, 1999
- Assessment of menstrual blood loss using a pictorial chartBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Racial Differences in Ristocetin‐induced Platelet AggregationBritish Journal of Haematology, 1981